FutuRx Overview

  • Investor Type
  • Accelerator/​Incubator

  • Status
  • Active

  • Investments
  • 16

  • Portfolio
  • 9

  • Exits
  • 5

Exits

FutuRx General Information

Description

FutuRx is the Israeli biotechnology accelerator that was established in 2014 by OrbiMed Israel Partners, Johnson & Johnson Innovation and Johnson & Johnson Development Corporation (JJDC) and Takeda Ventures Inc. The firm invests in new biotechnology products.

Contact Information

Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Accelerator/Incubator
Primary Office
  • Weizmann Science Park
  • Ness Ziona
  • Israel

FutuRx Investments (16)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
A2i Therapeutics 18-Dec-2020 Seed Round Drug Discovery Startup 00000000 000000 00000000 00.0
000 000000000000 01-Nov-2020 00000 000000 Drug Discovery Startup
0000 000000000000 01-May-2020 000000000000 000 Drug Discovery Startup
0000000 0000000000 12-Nov-2019 00000 00000 00.00 Drug Discovery Pre-Clinical Trials 00000000 000000 00000000 00.0
00000000 000000000 14-Jan-2019 000000000000 000 Drug Discovery Startup
0000 000 01-Jan-2019 000000000000 000 Drug Discovery Startup
000000 000 0000000 01-Oct-2018 0000 00000 000 Biotechnology Startup
000000000 01-Aug-2016 000000000000 Drug Discovery Out of Business 00000 000000 00.0
ProteKt Therapeutics 01-Dec-2015 Accelerator/Incubator 00.000 Drug Discovery Pre-Clinical Trials 00000000 000000 00000000 00.0
Pi Therapeutics 01-Mar-2015 Accelerator/Incubator Drug Discovery Out of Business
You’re viewing 10 of 16 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FutuRx Exits (5)

Company Name Exit Date Exit Type Exit Size
Pi Therapeutics 24-Sep-2021 Out of Business
00000 13-Dec-2019 000000000 00000000
000000 01-Sep-2019 000 00 00000000
Mitoconix 01-Jul-2019 Out of Business
HepaRx 01-Jan-2018 Out of Business
To view FutuRx’s complete exits history, request access »

FutuRx Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

FutuRx Team (3)

Name Title Deals Funds Boards Office
Kinneret Livnat Savitzky Ph.D Chief Executive Officer 0 0 Ness Ziona, Israel
Einat Zisman Ph.D Chief Executive Officer 0 Ness Ziona, Israel
Daria Mochly-Rosen Ph.D Founder Ness Ziona, Israel
To view FutuRx’s complete team members history, request access »

FutuRx Co-Investors (9)

Name With Exits Lead Partner Series Industry
Israel Innovation Authority 4 0 Series chart Industry bar
RMGLOBAL Healthcare Fund Management 0 0 Series chart Industry bar
Johnson & Johnson Innovation - JJDC 0 0 Series chart Industry bar
OrbiMed 0 0 Series chart Industry bar
Takeda Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 9 co-investors. Get the full list »